138 related articles for article (PubMed ID: 37304671)
1. Anticancer efficacy of 3-(4-isopropyl) benzylidene-8-ethoxy, 6-methyl, chroman-4-one (SBL-060), a novel, dual, estrogen receptor-Akt kinase inhibitor in acute myeloid leukemia cells.
Shahrani MA; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y; Gahtani RM; Radhakrishnan S; Dagreery K
Oncol Res; 2021; 29(3):149-157. PubMed ID: 37304671
[TBL] [Abstract][Full Text] [Related]
2. A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells.
Kamli H; Zaman GS; Shaikh A; Mobarki AA; Rajagopalan P
Oncol Res; 2022 Jan; 28(9):899-911. PubMed ID: 34353411
[TBL] [Abstract][Full Text] [Related]
3. Identification of second generation benzylidene chromanone analogues as novel, potent DHODH inhibitors in acute myeloid leukemia cells.
Abohassan M; Al Shahrani M; Rajagopalan P
J Biomol Struct Dyn; 2023; 41(13):6168-6177. PubMed ID: 35869648
[TBL] [Abstract][Full Text] [Related]
4. Structure activity evaluation and computational analysis identify potent, novel 3-benzylidene chroman-4-one analogs with anti-fungal, anti-oxidant, and anti-cancer activities.
Zaman GS; Kamli H; Radhakrishnan S; Ahmad I; Otifi H; Alshahrani MY; Rajagopalan P
Drug Dev Ind Pharm; 2021 Sep; 47(9):1459-1468. PubMed ID: 34726982
[TBL] [Abstract][Full Text] [Related]
5. GC/MS characterization and computational kinome-wide screening of pomegranate fruit extract identifies key phytochemicals interacting to CDK kinases implicated in acute myeloid leukemia cells.
Abohassan M; Al Shahrani M; Ahmad I; Abullais SS; Srivastava S; Rajagopalan P
J Food Biochem; 2022 Aug; 46(8):e14178. PubMed ID: 35451509
[TBL] [Abstract][Full Text] [Related]
6. Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations.
Abohassan M; Alshahrani M; Alshahrani MY; Rajagopalan P
Med Oncol; 2022 Oct; 39(12):249. PubMed ID: 36209300
[TBL] [Abstract][Full Text] [Related]
7. CB-RAF600E-1 exerts efficacy in vemurafenib-resistant and non-resistant-melanoma cells via dual inhibition of RAS/RAF/MEK/ERK and PI3K/Akt signaling pathways.
Al Shahrani M; Rajagopalan P; Abohassan M; Alshahrani M; Alraey Y
Saudi J Biol Sci; 2022 Jun; 29(6):103285. PubMed ID: 35592740
[TBL] [Abstract][Full Text] [Related]
8. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
[TBL] [Abstract][Full Text] [Related]
9. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
10. O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia.
Yen SC; Wu YW; Huang CC; Chao MW; Tu HJ; Chen LC; Lin TE; Sung TY; Tseng HJ; Chu JC; Huang WJ; Yang CR; HuangFu WC; Pan SL; Hsu KC
Phytomedicine; 2022 Jun; 100():154061. PubMed ID: 35364561
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
12. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
13. Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT.
Zhou H; Ning Y; Zeng G; Zhou C; Ding X
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649826
[TBL] [Abstract][Full Text] [Related]
14. AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
Barbarroja N; Torres LA; Rodriguez-Ariza A; Valverde-Estepa A; Lopez-Sanchez LM; Ruiz-Limon P; Perez-Sanchez C; Carretero RM; Velasco F; López-Pedrera C
Exp Hematol; 2010 Aug; 38(8):641-52. PubMed ID: 20380868
[TBL] [Abstract][Full Text] [Related]
15. Molecular target therapy of AKT and NF-kB signaling pathways and multidrug resistance by specific cell penetrating inhibitor peptides in HL-60 cells.
Davoudi Z; Akbarzadeh A; Rahmatiyamchi M; Movassaghpour AA; Alipour M; Nejati-Koshki K; Sadeghi Z; Dariushnejad H; Zarghami N
Asian Pac J Cancer Prev; 2014; 15(10):4353-8. PubMed ID: 24935396
[TBL] [Abstract][Full Text] [Related]
16. Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.
Lu H; Weng XQ; Sheng Y; Wu J; Xi HM; Cai X
BMC Cancer; 2022 Jul; 22(1):749. PubMed ID: 35810308
[TBL] [Abstract][Full Text] [Related]
17. The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell Line.
Taghiloo S; Norozi S; Asgarian-Omran H
Iran J Allergy Asthma Immunol; 2022 Apr; 21(2):178-188. PubMed ID: 35490271
[TBL] [Abstract][Full Text] [Related]
18. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
Sun X; Yang S; Song W
Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
[TBL] [Abstract][Full Text] [Related]
19. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1.
Shapourian H; Ghanadian M; Eskandari N; Shokouhi A; Demirel GY; Bazhin AV; Ganjalikhani-Hakemi M
BMC Cancer; 2024 Jan; 24(1):125. PubMed ID: 38267906
[TBL] [Abstract][Full Text] [Related]
20. Matrine induces apoptosis in human acute myeloid leukemia cells via the mitochondrial pathway and Akt inactivation.
Zhang S; Zhang Y; Zhuang Y; Wang J; Ye J; Zhang S; Wu J; Yu K; Han Y
PLoS One; 2012; 7(10):e46853. PubMed ID: 23056487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
